Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Springer

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Diabetes, Obesity & Metabolism|January 29, 2011
Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndromeP U Feig, S Shah, A Hermanowski-Vosatka, et al.
Journal of Medicinal Chemistry|January 24, 1992
Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor bindingT J Lanza, P L Durette, T Rollins, et al.
The Journal of Biological Chemistry|July 11, 1998
Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptorsY Weng, S J Siciliano, K E Waldburger, et al.
Virology|August 29, 1998
The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteinsC M Hill, D Kwon, M Jones, et al.
Nature|February 24, 2001
Parallel adaptive radiations in two major clades of placental mammalsO Madsen, M Scally, C J Douady, et al.
The Journal of Experimental Medicine|March 1, 1993
Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activationC S Lin, R C Boltz, J T Blake, et al.
The Journal of Biological Chemistry|January 16, 1999
A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1S J Siciliano, S E Kuhmann, Y Weng, et al.
Science (New York, N.Y.)|December 18, 2001
Resolution of the early placental mammal radiation using Bayesian phylogeneticsW J Murphy, E Eizirik, S J O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanesP E Finke, L C Meurer, B Oates, et al.
European Journal of Immunology|February 17, 1998
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cellsS Ying, D S Robinson, Q Meng, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Diabetes, Obesity & Metabolism|January 29, 2011
Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndromeP U Feig, S Shah, A Hermanowski-Vosatka, et al.
Journal of Medicinal Chemistry|January 24, 1992
Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor bindingT J Lanza, P L Durette, T Rollins, et al.
The Journal of Biological Chemistry|July 11, 1998
Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptorsY Weng, S J Siciliano, K E Waldburger, et al.
Virology|August 29, 1998
The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteinsC M Hill, D Kwon, M Jones, et al.
Nature|February 24, 2001
Parallel adaptive radiations in two major clades of placental mammalsO Madsen, M Scally, C J Douady, et al.
The Journal of Experimental Medicine|March 1, 1993
Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activationC S Lin, R C Boltz, J T Blake, et al.
The Journal of Biological Chemistry|January 16, 1999
A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1S J Siciliano, S E Kuhmann, Y Weng, et al.
Science (New York, N.Y.)|December 18, 2001
Resolution of the early placental mammal radiation using Bayesian phylogeneticsW J Murphy, E Eizirik, S J O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanesP E Finke, L C Meurer, B Oates, et al.
European Journal of Immunology|February 17, 1998
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cellsS Ying, D S Robinson, Q Meng, et al.
Pageof 8